{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:45:11Z","timestamp":1792755911319,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI046464"],"award-info":[{"award-number":["R01 AI046464"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI114701"],"award-info":[{"award-number":["R01 AI114701"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI099125"],"award-info":[{"award-number":["R01 AI099125"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R41 AI124759"],"award-info":[{"award-number":["R41 AI124759"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI114790"],"award-info":[{"award-number":["R01 AI114790"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI118161"],"award-info":[{"award-number":["U01 AI118161"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["C06 RR016226)"],"award-info":[{"award-number":["C06 RR016226)"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.1093\/infdis\/jiy609","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T15:11:48Z","timestamp":1539357108000},"page":"1130-1137","source":"Crossref","is-referenced-by-count":53,"title":["A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5734-083X","authenticated-orcid":false,"given":"Peter T","family":"Beernink","sequence":"first","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, University of California\u2013San Francisco (UCSF) Benioff Children\u2019s Hospital, Oakland"},{"name":"Department of Pediatrics, School of Medicine, UCSF, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ispasanie","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, University of California\u2013San Francisco (UCSF) Benioff Children\u2019s Hospital, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R","family":"Moe","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, University of California\u2013San Francisco (UCSF) Benioff Children\u2019s Hospital, Oakland"},{"name":"Department of Pediatrics, School of Medicine, UCSF, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M","family":"Granoff","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, University of California\u2013San Francisco (UCSF) Benioff Children\u2019s Hospital, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"key\n\t\t\t\t2019031513463150000_CIT0001","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0002","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0915162107","article-title":"Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans","volume":"107","author":"Serruto","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0003","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/589308","article-title":"Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin","volume":"198","author":"Koeberling","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/infdis\/135.4.669","article-title":"Neisseria meningitidis infections in Northern Norway: an epidemic in 1974\u20131975 due mainly to group B organisms","volume":"135","author":"Bovre","year":"1977","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0006","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1073\/pnas.83.13.4927","article-title":"Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease","volume":"83","author":"Caugant","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0007","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.vaccine.2005.01.061","article-title":"From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease","volume":"23","author":"O\u2019Hallahan","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0008","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/INF.0000000000001296","article-title":"Neonatal meningococcal meningitis in France from 2001 to 2013","volume":"35","author":"Bilal","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0009","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/432102","article-title":"Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870","volume":"192","author":"Hou","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0011","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1016\/j.vaccine.2011.04.095","article-title":"Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys","volume":"29","author":"Koeberling","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0012","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0013","first-page":"53","article-title":"Mucosal approaches in Neisseria vaccinology","volume":"18","author":"P\u00e9rez","year":"2009","journal-title":"VacciMonitor"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0014","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3201\/eid2206.151093","article-title":"Ecologic study of meningococcal B vaccine and Neisseria gonorrhoeae infection, Norway","volume":"22","author":"Whelan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0015","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.4161\/hv.36221","article-title":"Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: results from a decision-analysis model","volume":"10","author":"R\u00e9gnier","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0016","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0017","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination","volume":"186","author":"Beernink","year":"2011","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0018","doi-asserted-by":"crossref","first-page":"e1002688","DOI":"10.1371\/journal.ppat.1002688","article-title":"The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein","volume":"8","author":"Beernink","year":"2012","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0019","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"van der Ley","year":"2001","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0020","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1128\/JB.183.19.5472-5481.2001","article-title":"Multiple origins and replication proteins influence biological properties of beta-lactamase-producing plasmids from Neisseria gonorrhoeae","volume":"183","author":"Pagotto","year":"2001","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/1-59259-148-5:81","article-title":"Outer membrane vesicle vaccines for meningococcal disease","volume-title":"Meningococcal vaccines: methods and protocols","author":"Frasch","year":"2001"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0022","first-page":"e00430","article-title":"Serum bactericidal antibody responses of adults immunized with the MenB-4C vaccine against genetically diverse serogroup B meningococci","volume":"5","author":"Giuntini","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0023","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00121-17","article-title":"Breadth and duration of meningococcal serum bactericidal activity in health care workers and microbiologists immunized with the MenB-FHbp vaccine","volume":"24","author":"Lujan","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0024","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1086\/514821","article-title":"Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine","volume":"195","author":"Beernink","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0025","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/CVI.00474-15","article-title":"Susceptibility of meningococcal strains responsible for two serogroup B outbreaks on U.S. university campuses to serum bactericidal activity elicited by the MenB-4C Vaccine","volume":"22","author":"Rossi","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0026","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1514866","article-title":"Immunogenicity of a meningococcal B vaccine during a university outbreak","volume":"375","author":"Basta","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12866-015-0469-6","article-title":"Characterization of invasive Neisseria meningitidis strains from Quebec, Canada, during a period of increased serogroup B disease, 2009\u20132013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets","volume":"15","author":"Law","year":"2015","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0028","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/JCM.00601-06","article-title":"Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19)","volume":"44","author":"Law","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/IAI.00751-12","article-title":"Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing","volume":"81","author":"Lewis","year":"2013","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1567-5769(00)00037-0","article-title":"C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae","volume":"1","author":"Ram","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0031","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.4049\/jimmunol.1102746","article-title":"Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein","volume":"188","author":"Gulati","year":"2012","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0032","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/CVI.00542-10","article-title":"A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines","volume":"18","author":"Koeberling","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0033","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0034","doi-asserted-by":"crossref","first-page":"e1003528","DOI":"10.1371\/journal.ppat.1003528","article-title":"Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein","volume":"9","author":"Jongerius","year":"2013","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0035","first-page":"LB-3","volume-title":"Possible impact of wide-scale vaccination against serogroup B Neisseria meningitidis on gonorrhea incidence rates in one region of Quebec, Canada. ID Week 2017","author":"Longtin","year":"2017"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0036","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/174.6.1223","article-title":"Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids","volume":"174","author":"Gulati","year":"1996","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0037","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0038","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1016\/j.vaccine.2010.08.048","article-title":"A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA","volume":"28","author":"Keiser","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0039","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","article-title":"Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates","volume":"28","author":"Pajon","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0040","doi-asserted-by":"crossref","first-page":"e01625","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"MBio"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0041","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/infdis\/jiv081","article-title":"Binding of complement factor H (FH) decreases protective anti-FH binding protein antibody responses of infant rhesus macaques immunized with a meningococcal serogroup B vaccine","volume":"212","author":"Granoff","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0042","doi-asserted-by":"crossref","first-page":"e88907","DOI":"10.1172\/jci.insight.88907","article-title":"Enhanced protective activity to a mutant meningococcal factor H-binding protein vaccine with low-factor H binding","volume":"1","author":"Granoff","year":"2016","journal-title":"JCI Insight"},{"key":"key\n\t\t\t\t2019031513463150000_CIT0043","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/JB.01331-10","article-title":"Genome sequence of Neisseria meningitidis serogroup B strain H44\/76","volume":"193","author":"Piet","year":"2011","journal-title":"J Bacteriol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/7\/1130\/28080024\/jiy609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T01:56:58Z","timestamp":1552701418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/7\/1130\/5139647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,10,20]]},"published-print":{"date-parts":[[2019,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy609","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2018,10,20]]}}}